Jorveza

Medicinal product

(Invented) name

Jorveza

Active substance (s)

Budezonidas

Strength

0,2 mg

Pharmaceutical form

geriamoji suspensija

Route (s) of administration

vartoti per burną

Purpose for use

2–17 metų vaikams ir paaugliams

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A07EA06, Budesonide

Marketing authorisation holder

Dr. Falk Pharma GmbH, Vokietija

Date of authorisation

2018-01-08

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

1 ml suspensijos yra:	1 ml
Budezonidas	0,2 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
120532	106636	1106636	buteliukas	165 ml N1 (+ geriamasis švirkštas)		Receptinis	EU/1/17/1254/012	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2018-01-08	Registruotas